September 23 | 8am PST · 11am EST · 5pm CET
Speaker: Dr. Deborah Piffaretti, Institute of Oncology Research (IOR)
Is clonal hematopoiesis (CH) truly a driver of diffuse large B-cell lymphoma (DLBCL)?
This webinar will explore the latest evidence from large patient cohorts, single-cell multiomics, and functional models to address this critical question.
How to interpret single-cell data to distinguish CH from DLBCL mutations
Ways to rigorously evaluate microenvironment enrichment claims
Approaches to reprioritize mechanisms most likely driving DLBCL